| Anderson, Daniel M |
Healthpartners Institute
United States |
Metro-Minnesota Community Oncology Research Consortium (MMCORC) |
5UG1CA189863-11 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Chan, Alexandre |
University Of California-Irvine
United States |
Neurotrophic strategy to mitigate chemotherapy-related brain injury |
1R01CA276212-01A1 |
PAR-21-329 (R01 Clinical Trial Optional) |
Catherine Schweppe, Ph.D. |
| Santos-Reyes, Luis Javier |
Comprehensive Cancer Center/ Univ/Pr
United States |
Puerto Rico Minority Underserved NCI Community Oncology Research Program (Puerto Rico MUNCORP) |
5UG1CA189862-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Feng, Ziding |
Fred Hutchinson Cancer Center
United States |
Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) |
2U24CA230144-07 |
|
Guillermo Marquez, Ph.D. |
| Vinciguerra, Vincent P |
Feinstein Institute For Medical Research
United States |
Northwell Health NCORP |
5UG1CA189850-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Garcia, Jose M. |
Seattle Inst For Biomedical/Clinical Res
United States |
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) |
1R01CA279220-01A1 |
|
Marge Good, R.N., M.P.H., O.C.N. |
| Balmain, Allan |
University Of California, San Francisco
United States |
PROMINENT - UCSF |
3OT2CA278665-01S1 |
|
|
| Rowland, Kendrith Martin |
Carle Foundation
United States |
Carle Cancer Center NCI Community Oncology Research Program (NCORP) |
5UG1CA189861-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Soragni, Alice |
University Of California Los Angeles
United States |
Targeting p53 conformational defects to arrest carcinogenesis |
5R01CA240718-05 |
|
Goli Samimi, Ph.D., M.P.H. |
| Gross, Howard M |
Dayton Clinical Oncology Program
United States |
Dayton Clinical Oncology Program |
5UG1CA189957-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |